NAFLD is the most common liver disease worldwide but it is the potential evolution to cirrhosis and hepatocellular carcinoma (HCC) that makes NAFLD of such clinical importance. The current work provides an overview of the main mechanims and potential therapeutical insights involved in NAFLD, NASH, fibrosis and HCC progression.
From NAFLD to NASH and HCC: Pathogenetic Mechanisms and Therapeutic Insights / DE MINICIS, Samuele; C., Day; SVEGLIATI BARONI, Gianluca. - In: CURRENT PHARMACEUTICAL DESIGN. - ISSN 1381-6128. - (2013).
From NAFLD to NASH and HCC: Pathogenetic Mechanisms and Therapeutic Insights.
DE MINICIS, SAMUELE;SVEGLIATI BARONI, Gianluca
2013-01-01
Abstract
NAFLD is the most common liver disease worldwide but it is the potential evolution to cirrhosis and hepatocellular carcinoma (HCC) that makes NAFLD of such clinical importance. The current work provides an overview of the main mechanims and potential therapeutical insights involved in NAFLD, NASH, fibrosis and HCC progression.File in questo prodotto:
Non ci sono file associati a questo prodotto.
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
